APA (7th ed.) Citation

Ungan, G., Pons‐Escoda, A., Ulinic, D., Arús, C., Ortega‐Martorell, S., Olier, I., . . . Julià‐Sapé, M. (2024). Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous. NMR in biomedicine, 37(4), e5095-n/a. https://doi.org/10.1002/nbm.5095

Chicago Style (17th ed.) Citation

Ungan, Gülnur, Albert Pons‐Escoda, Daniel Ulinic, Carles Arús, Sandra Ortega‐Martorell, Ivan Olier, Alfredo Vellido, Carles Majós, and Margarida Julià‐Sapé. "Early Pseudoprogression and Progression Lesions in Glioblastoma Patients Are Both Metabolically Heterogeneous." NMR in Biomedicine 37, no. 4 (2024): e5095-n/a. https://doi.org/10.1002/nbm.5095.

MLA (9th ed.) Citation

Ungan, Gülnur, et al. "Early Pseudoprogression and Progression Lesions in Glioblastoma Patients Are Both Metabolically Heterogeneous." NMR in Biomedicine, vol. 37, no. 4, 2024, pp. e5095-n/a, https://doi.org/10.1002/nbm.5095.